Skip to main content

Journey Advisory Group, LLC

SEC CIK
0001840085
Latest filing
Aug 4, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Journey Advisory Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
14,912
Value
$1.35M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Journey Advisory Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614,912$1.35M0.1%−659−4.2%ReducedHolders
Q1 202615,571$1.60M0.1%−1,128−6.8%ReducedHolders
Q4 202516,699$2.09M0.2%−171−1.0%ReducedHolders
Q3 202516,870$2.26M0.2%−1,949−10.4%ReducedHolders
Q2 202518,819$2.56M0.2%−37−0.2%ReducedHolders
Q1 202518,856$2.50M0.2%−1,111−5.6%ReducedHolders
Q4 202419,967$2.07M0.2%00.0%UnchangedHolders
Q3 202419,967$2.07M0.2%00.0%UnchangedHolders
Q2 202419,967$2.07M0.2%−266−1.3%ReducedHolders
Q1 202420,233$2.30M0.3%−308−1.5%ReducedHolders
Q4 202320,541$2.26M0.3%−45−0.2%ReducedHolders
Q3 202320,586$1.99M0.3%−117−0.6%ReducedHolders
Q2 202320,703$2.26M0.3%−2,918−12.4%ReducedHolders
Q1 202323,621$2.39M0.4%−7,719−24.6%ReducedHolders
Q4 202231,340$3.44M0.9%−3,667−10.5%ReducedHolders
Q3 202235,007$3.39M0.9%−4,370−11.1%ReducedHolders
Q2 202239,377$4.31M1.0%+4,280+12.2%AddedHolders
Q1 202235,097$4.15M1.1%+2,447+7.5%AddedHolders
Q4 202132,650$4.59M1.3%+327+1.0%AddedHolders
Q3 202132,323$3.82M1.2%+386+1.2%AddedHolders
Q2 202131,937$3.70M1.2%+944+3.0%AddedHolders
Q1 202130,993$3.71M1.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.